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Introduction
cAMP-responsive element-binding proteins (CREBs) and activating transcription factors (ATFs) are basic region leucine zipper protein, which act as transcriptional activators or repressors. Activating transcription factor-4 (ATF4), a member of CREB/ATF family, is ubiquitously expressed throughout the body and is induced in response to various stress signals including anoxia, hypoxia, endoplasmic reticulum stress, amino acid deprivation, and oxidative stress (1) . The stress-induced expression of ATF4 causes adaptive responses in cells through regulating the expression of target genes involved in amino acid synthesis, differentiation, metastasis, angiogenesis, and drug resistance (1) . Excessive expression of ATF4 is often observed in malignant tumors in both human and rodents (2) . The highly expressed ATF4 is thought to facilitate tumor progression, because transcription of genes involved in tumor cell proliferation is modulated by ATF4 (3). However, the role of ATF4 in the malignant transformation of normal cells remains to be elucidated.
In this study, we found that embryonic fibroblasts prepared from Atf4-null (Atf4-/-) mice showed resistance to oncogenic transformation induced by concomitant expression of proto-oncogenic RAS (H-ras V12 ) and simian virus 40 large T-antigen (SV40LT). On the basis of these findings, we further characterized the role of ATF4 during the malignant transformation. Our present results suggest that ATF4 acts as a suppressor of cellular senescence thereby promoting oncogenic transformation. Author Manuscript Published OnlineFirst on November 18, 2011; DOI: 10.1158/0008-5472. CAN-11-1891 5 to the Gene Expression Omnibus at the National Center for Biotechnology Information (accession number GSE31405). The functional analysis of the differentially expressed genes was done by using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database on DAVID system (6).
Materials and methods

Animals and cells. Heterozygous
Quantitative RT-PCR analysis. The complementary DNA (cDNA) was synthesized by reverse-transcribing using ReverTra Ace qPCR RT kit (Toyobo, Osaka, Japan) (7).
Diluted cDNA samples were analyzed by real-time PCR using THUNDERBIRD TM SYBR qPCR Mix (Toyobo) and the 7500 Real-time PCR system (Applied Biosystems).
Sequences for PCR primers are described in Supplementary Table S1 .
Luciferase reporter assay. The surround regions of C/EBP-ATF response element (CARE) in the mouse p16Ink4a and p19ARF promoter were amplified using DNA extracted from wild-type MEFs. The PCR products were ligated into a pGL4 Basic vector (p16Ink4a-Luc and p19ARF-Luc) as shown in Supplementary Fig. S1 . The sequences of the CARE in luciferase vectors were mutated using a QuickChange site-directed mutagenesis kit (Strategene, La Jolla, CA). Expression vectors for mouse ATF4 and C/EBPα were constructed as described previously (5). MEFs were transfected with 100 ng per well of reporter vectors and 500 ng per well of expression vectors using Lipofectamine LTX reagent (Invitrogen). phRL-TK vector (Promega) at 0.5 ng per well of was also cotransfected as an internal control reporter.
Chromatin immunoprecipitation assays. MEFs were treated with 8%
paraformaldehyde to cross-link the chromatin. Those samples were incubated with Cruz, CA). Chromatin/antibody complexes were extracted using a protein G agarose kit (Roche, Germany). Isolated DNA was subjected to PCR using the following primer pair: 
Results and Discussion
To characterize the role of ATF4 in oncogenic transformation, we prepared mouse MEFs from wild-type and Atf4-/-mice, and infected the cells concomitantly with retrovirus vectors expressing the H-ras V12 and the SV40LT (4). These oncogenes were equally expressed in wild-type and Atf4-/-cells (Fig. S2A) . Comparison of flow cytometry (FACS) histograms from the wild-type and the Atf4-/-tumors also revealed a significant difference in the cell cycle distribution between the genotypes. As compared to wild-type tumor cells, Atf4-/-cells were highly accumulated in the G0/G1 phase, whereas the population of the G2/M phase of Atf4-/-cells was considerably smaller than that of wild-type cells (Fig. 1D) . These results indicate that the loss of ATF4 attenuates the tumorigenicity of mouse fibroblasts and the G0/G1 phase arrest of the cell cycle underlies the resistance of Atf4-/-cells to oncogenic transformation.
To identify genes that enable Atf4-/-cells to resist oncogenic transformation, we performed microarray analysis using RNA isolated from oncogene-introduced wild-type or Atf4-/-cells. A large number of genes would be induced or repressed by oncogenic stimuli. We thus focused on genes whose responsiveness to oncogenic stimuli was altered in Atf4-/-cells. On day 7 after concomitant introduction of H-ras V12 and SV40LT, 326 genes in Atf4-/-cells were differentially expressed as compared to wild-type cells.
Among these genes, 216 genes in Atf4-/-cells were up-regulated by oncogenic stimuli, whereas 110 genes were down-regulated in oncogene-infected Atf4-/-cells (Supplementary Table S2 ). The functional analysis of the genes, done using KEGG database (6), showed that 12 biological pathways were enriched in a statistically significant manner (P<0.05; Table S3 ). Among these pathways, we further focused on the cell cycle pathway because Atf4-/-cells introduced with oncogenes resulted in G0/G1
phase arrest (Fig. 1D) . In this pathway, only Cdkn2a, a canonical inducer of cellular Recent studies have demonstrated that tumor suppressor gene Cdkn2a acts as a canonical inducer of cellular senescence (8, 9) . Cdkn2a generates several different transcript variants using different first exons and alternate polyadenylation sites ( Fig. 2A) (10,11). The p16Ink4a variants encode structurally related protein isoforms that inhibit CDK4 kinase (9) . The CDK4 inhibitor prevents phosphorylation of Rb by disrupting the activity of CDK4-Cyclin D complex, thereby causing G1 phase arrest. The remaining transcript includes an alternate first exon located 20 kb upstream from the remainder of the p16Ink4a gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to that of p16INK4a protein (10, 11) . p19ARF (also known as p14ARF in human) stabilizes p53 by sequestering MDM2, a protein responsible for degrading p53 (12) . In spite of the structural and functional differences, p16INK4a and p19ARF play an important role in the cell cycle's G1/S progression: the induction of these proteins is critical for causing cellular senescence (8, 9) . Introduction of H-ras V12 and SV40LT into wild-type cells significantly and consistently increased the levels of Atf4 mRNA and its protein throughout the experimental period ( Fig. 2B and C) . Introduction of the oncogene also induced the expression of p16INK4a and p19ARF, but the induction was transient; mRNA levels of cellular senescence-associated genes reached a peak level from 1 to 2 days after oncogene introduction and decreased to basal level within 4 days ( Fig. 2B and C) . In contrast,
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introduction of H-ras V12 and SV40LT into Atf4-/-cells caused a significant and consistent increase in the expression of p16INK4a and p19ARF at both mRNA and protein levels (P<0.05; Fig. 2B and C) . The increase in the expression of p16INK4a and p19ARF in oncogene-introduced Atf4-/-cells was suppressed by ectopic expression of ATF4 (Fig.   2D) , suggesting that excess ATF4 suppresses the expression of cellular senescence-associated genes induced by oncogenic stimuli.
ATF4 positively or negatively regulate the transcription of its target genes by forming homo-or hetero-dimer with Jun, AP-1, and CCAAT/enhancer binding proteins (C/EBPs) (13,14). The dimerization partners appear to determine the diverse actions of ATF4. The heterodimerization of ATF4 with C/EBPα represses transcription on CARE (15) . A consensus sequence of CARE was found in the upstream region of mouse p16Ink4a gene (Fig. 2A) . The sequence inspection of the upstream region of mouse p19ARF gene also revealed a CARE that matches 8 bp of the 9 bp consensus sequence TGATGXAAX (where X = A, T, or C). The CARE sequences were located at similar position on the human CDKN2A locus. To explore whether ATF4 acts as a transcriptional repressor of cellular senescence-associated genes, we constructed two luciferase reporter vectors containing the CARE derived from the upstream region of mouse p16Ink4a and p19ARF. Neither ATF4 nor C/EBPα had a considerable effect on the luciferase activity of p16Ink4a-Luc, but co-transfection of p16Ink4a-Luc with both ATF4 and C/EBPα resulted in a 90% reduction of the luciferase activity (Fig. 2E) . A similar transrepression was also found when cells were co-transfection of p19ARF-Luc with both ATF4 and C/EBPα (Fig. 2E) . The transrepression effects of ATF4-C/EBPα on the p16Ink4a-Luc and p19ARF-Luc were dependent on the CAREs, because mutation of CAN-11-1891 the sequences attenuated the suppressive action of ATF4-C/EBPα to the basal level (Fig. 
2E).
The results from chromatin immunoprecipitation analysis also revealed that the amounts of ATF4 binding to the Cdkn2a locus CARE located on the upstream of p16Ink4a in wild-type cells consistently increased from day 3 after introduction of H-ras V12 and SV40LT (Fig. 2F) . On the other hand, no obvious binding of ATF4 to the 05; Fig. 3D ). Since mice inoculated with Atf4-/-cells introduced with oncogenes showed a modest tumorigenicity (Fig. 1C) , the induction of cellular senescence and apoptotic cell death seemed to be associated with modest tumor formation of Atf4-/-cells.
In this study, we used retrovirus vectors expressing SV40LT as a transforming agent, together with H-ras V12 . As SV40LT inactivates p53 and prevents the phosphorylation of Rb by protein-protein interaction (18, 19) , the SV40LT-transduced cells are thought to be insensitive to growth arrest by p16INK4a and p19ARF.
Inactivation of the growth-suppressive properties of p53 has shown to be essential for immortalization of MEFs by SV40LT (18) . Concomitant introduction of H-ras V12 and SV40LT induced the expression of p53 in Atf4-/-cells, so that the amount of p53 proteins in oncogene-introduced Atf4-/-cells was much greater than that in wild-type cells (Fig.   S3) . The most amount of p53 protein in oncogene-introduced wild-type cells was precipitated together with SV40LT (Fig. S4) . However, a large amount of p53 protein in Atf4-/-cells was unable to be precipitated together with SV40LT, suggesting that extensive expression of p53 in oncogene-introduced Atf4-/-cells overrides the binding capacity of SV40LT, and allows induction of cellular senescence.
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The present findings suggest the mechanism by which ATF4 promotes oncogenic transformation by suppressing the expression of cellular senescence-associated proteins (Fig. 3E) . ATF4, p16INK4a, and p19ARF are expressed in response to oncogenic stimuli, but in turn, an overabundance of ATF4 suppresses the expression of these cellular senescence-associated proteins through binding to the CARE in the Cdkn2a locus.
Decreases in the levels of cellular senescence-associated proteins restore stabilization of (n = 3-9). **P <0.01, compared between the two groups. #P < 0.05 compared with wild-type group at the corresponding day. 
